Tg Therapeutics (TGTX) Return on Assets Growth (3y) (2014 - 2026)

Tg Therapeutics (TGTX) Return on Assets Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Tg Therapeutics 8.08 Bn 8.00 Bn 171.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00
Dec 31, 2025 2.00
Sep 30, 2025 2.00
Jun 30, 2025 1.00
Mar 31, 2025 1.00
Dec 31, 2024 1.00
Sep 30, 2024 1.00
Jun 30, 2024 99.00
Mar 31, 2024 145.00
Dec 31, 2023 209.00
Sep 30, 2023 331.00
Jun 30, 2023 226.00
Mar 31, 2023 83.00
Dec 31, 2022 60.00
Sep 30, 2022 77.00
Jun 30, 2022 52.00
Mar 31, 2022 66.00
Dec 31, 2021 23.00
Sep 30, 2021 18.00
Jun 30, 2021 -81.00